Gemcitabine-induced radiation recall

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 2, 2002, Pages 394-400

  Jeter, Melenda D ^a   Jänne, Pasi A ^b   Brooks, Sarah ^b   Burstein, Harold J ^b   Wen, Patrick ^b   Fuchs, Charles S ^b   Loeffler, Jay S ^c   Devlin, Phillip M ^b   Salgia, Ravi ^b,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; DOSIMETRY; GASTROENTEROLOGY; IRRADIATION; MUSCULOSKELETAL SYSTEM; NEUROLOGY; SKIN; TOXICITY;

RADIATION RECALL;

ONCOLOGY;

ANTHRACYCLINE; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; EDATREXATE; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IBUPROFEN; IDARUBICIN; MELPHALAN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; STEROID; TAXANE DERIVATIVE; TRIMETREXATE; VINBLASTINE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BRAIN STEM; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DESQUAMATION; DOSE TIME EFFECT RELATION; DRUG WITHDRAWAL; ENTERITIS; ERYTHEMA; FEMALE; GASTROINTESTINAL TRACT; HUMAN; LYMPHANGITIS; LYMPHATIC SYSTEM; MALE; MOUTH INFLAMMATION; MUCOSA INFLAMMATION; MUSCULOSKELETAL SYSTEM; OPTIC NERVE DISEASE; PNEUMONIA; PRIORITY JOURNAL; RADIATION NECROSIS; RADIATION SICKNESS; RETROSPECTIVE STUDY; SKIN; SKIN MANIFESTATION; STEROID THERAPY; STOMATITIS; TISSUE DISTRIBUTION; TREATMENT OUTCOME; VULVITIS;

ADULT; AGED; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIATION INJURIES; RADIATION-SENSITIZING AGENTS; RETROSPECTIVE STUDIES;

EID: 0036603732     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02773-6     Document Type: Article

References (52)

1. Radiotherapy and chemotherapy
2. Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel
3. Potentiation of x-ray effects by actinomycin-D
4. Dermatologic toxicity
5. Mucocutaneous reactions to antineoplastic agents
6. Side effects of chemotherapy. Case 1. Radiation recall dermatitis from gemcitabine
7. Side effects of chemotherapy. Case 2. Radiation recall reaction induced by gemcitabine
8. Gemcitabine-mediated radiosensitization
9. Radiosensitization by gemcitabine
10. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
11. Gemcitabine: A cytidine analogue active against solid tumors
12. Effect of 2′,2′-difluorodeoxycytidine on the viability and radiosensitivity of EMT6 cells in vitro
13. Radiosensitizing nucleosides
14. Metabolism of 2′,2′-difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells
15. Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2′,2′-difluoro-2′-deoxycytidine (gemcitabine)
16. The role of apoptosis in 2′,2′-difluoro-2′-deoxycytidine (gemcitabine)-mediated radiosensitization
17. Radiation recall in a patient with breast cancer treated for tuberculosis
18. Radiation recall - Another call with tamoxifen
19. Sunlight-induced radiation recall
20. Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin's lymphoma of Waldeyer's ring
21. Radiation-recall enteritis after actinomycin-D and adriamycin therapy
22. Adriamycin and enhanced radiation reaction in normal esophagus and skin
23. Radiation recall associated with vinblastine in a patient treated for Kaposi sarcoma related to acquired immune deficiency syndrome
24. Radiation recall dermatitis induced by edatrexate in a patient with breast cancer
25. Paclitaxel-induced radiation recall dermatitis
26. Radiation recall induced by tamoxifen
27. Ultraviolet recall associated with etoposide and cyclophosphamide therapy
28. Adriamycin-induced recall phenomenon 15 years after radiotherapy
29. Mucocutaneous reactions to chemotherapy
30. The "recall effect" in radiotherapy: Is subeffective, reparable damage involved?
31. High yields of lethal mutations in somatic mammalian cells that survive ionizing radiation
32. Response of the normal eye to high dose radiotherapy
33. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas
34. Tolerance of normal tissue to therapeutic irradiation
35. Brainstem tolerance to conformal radiotherapy of skull base tumors
36. Radiation-recall dermatitis with docetaxel: Establishment of a requisite radiation threshold
37. Paclitaxel-induced radiation recall dermatitis
38. Taxol and radiation recall dermatitis
39. Paclitaxel and radiation-recall dermatitis
40. Radiation-recall dermatitis in a patient treated with paclitaxel
41. Docetaxel and radiation-recall severe mucositis
42. Radiation recall supraglottitis. A hazard in head and neck chemotherapy
43. Radiation recall reaction to idarubicin resulting in vaginal necrosis
44. Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome
45. Radiation recall associated with VP-16-213 therapy
46. Radiation recall dermatitis induced by methotrexate in a patient with Hodgkin's disease
47. A phase I study of trimetrexate, an analog of methotrexate, administered monthly in the form of nine consecutive daily bolus injections
48. Letter: Adriamycin activating a recall phenomenon after radiation therapy
49. Radiation-recall
50. Radiation-adriamycin interactions: Preliminary clinical observations
51. "Recall" pneumonitis: Adriamycin potentiation of radiation pneumonitis in two children
52. Radiation recall and radiosensitization with alkylating agents